# Ventyx Biosciences, Inc.

Ventyx Biosciences, Inc. is a company headquartered in San Diego, CA, United States.

## Company overview

- **Legal name:** Ventyx Biosciences, Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** San Diego, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001851194

## About

Ventyx Biosciences, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001851194, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2025-02-27, it reported net income of USD -135,122,000; total assets of USD 276,563,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2024 (period ended 2024-12-31)

- **Net income:** -$135.1M (USD -135,122,000)
- **Total assets:** $276.6M (USD 276,563,000)
- **Cash and equivalents:** $27.3M (USD 27,260,000)
- **Operating cash flow:** -$130.9M (USD -130,873,000)

### FY2023 (period ended 2023-12-31)

- **Net income:** -$193.0M (USD -192,962,000)
- **Total assets:** $277.7M (USD 277,693,000)
- **Cash and equivalents:** $51.6M (USD 51,579,000)
- **Operating cash flow:** -$166.5M (USD -166,522,000)

### FY2022 (period ended 2022-12-31)

- **Net income:** -$108.4M (USD -108,426,000)
- **Total assets:** $371.4M (USD 371,400,000)
- **Cash and equivalents:** $64.8M (USD 64,819,000)
- **Operating cash flow:** -$98.8M (USD -98,771,000)

### FY2021 (period ended 2021-12-31)

- **Net income:** -$83.7M (USD -83,746,000)
- **Total assets:** $291.5M (USD 291,482,000)
- **Cash and equivalents:** $70.8M (USD 70,791,000)
- **Operating cash flow:** -$38.6M (USD -38,650,000)

## Recent SEC filings

- Form 8-K — filed 2026-03-04 — period 2026-03-04 — 8-K
- Form 8-K — filed 2026-03-03 — period 2026-03-03 — 8-K
- Form 8-K — filed 2026-02-23 — period 2026-02-23 — 8-K
- Form 8-K — filed 2026-01-22 — period 2026-01-21 — 8-K
- Form 8-K — filed 2026-01-07 — period 2026-01-07 — 8-K
- Form 10-Q — filed 2025-11-06 — period 2025-09-30 — 10-Q
- Form 8-K — filed 2025-11-06 — period 2025-11-06 — 8-K
- Form 8-K — filed 2025-10-22 — period 2025-10-22 — 8-K
- Form 10-Q — filed 2025-08-07 — period 2025-06-30 — 10-Q
- Form 8-K — filed 2025-08-07 — period 2025-08-07 — 8-K
- Form 8-K — filed 2025-06-17 — period 2025-06-17 — 8-K
- Form 8-K — filed 2025-06-10 — period 2025-06-04 — 8-K

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/ventyx-biosciences-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology